Journals / İstanbul Kuzey Klinikleri / 2019 / Cilt: 6 - Sayı: 2

The effects of barnidipine on an experimental ischemia reperfusion model of spinal cord injury and comparison with methyl prednisolone

Pages
103–109
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no significant correlation between the ischemia and barnidipine-treated groups and thebarnidipine and methylprednisolone groups in terms of MDA levels (p>0.008).CONCLUSION: A single dose of barnidipine (10 mg/kg) and methylprednisolone are not effective and not sufficient to prevent spinal ischemia-reperfusion injury in rats.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Increased intracellular calcium concentration plays an important role in the secondary mechanism of spinalcord injury.
📊
Key Findings & Data:In the presenting experimental study, we aimed to evaluate the healing effect of barnidipine, which has a highaffinity for L-type calcium channels, on acute spinal cord injury and to compare its effects with those of methylprednisolone.METHODS: A total of 32 Spraque Dawley albino adult female rats were divided into 4 groups; group 1: sham-operated(n=8), group 2: only ischemia (n=6), group 3: barnidipine-treated (n=8), and group 4: methylprednisolone-treated (n=6).
💡
Conclusion & Impact:There was no significant correlation between the ischemia and barnidipine-treated groups and thebarnidipine and methylprednisolone groups in terms of MDA levels (p>0.008).CONCLUSION: A single dose of barnidipine (10 mg/kg) and methylprednisolone are not effective and not sufficient to prevent spinal ischemia-reperfusion injury in rats.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Increased intracellular calcium concentration plays an important role in the secondary mechanism of spinalcord injury. In the presenting experimental study, we aimed to evaluate the healing effect of barnidipine, which has a highaffinity for L-type calcium channels, on acute spinal cord injury and to compare its effects with those of methylprednisolone.METHODS: A total of 32 Spraque Dawley albino adult female rats were divided into 4 groups; group 1: sham-operated(n=8), group 2: only ischemia (n=6), group 3: barnidipine-treated (n=8), and group 4: methylprednisolone-treated (n=6). Anischemia-reperfusion model was created by clipping the abdominal aorta in the rats. Motor examination was performed 1 hourafter the surgical procedure and before sacrification. Immediately following the second motor examination, rats were sacrificed and tissue samples were taken for histopathological examination and for testing of tissue malondialdehyde (MDA) levels.RESULTS: A significant correlation of motor examination was found between the sham-operated and barnidipine-treatedgroups and the sham-operated and only ischemia groups at the 1st and 24th hour (p0.008). Light microscopic examination of the sham-operated group revealed findings consistent with normal spinal cordstructure. In group 2, 3, and 4, light microscopic examination revealed polymorphonuclear leukocyte infiltration and a smallamount of axonal swelling. There was no significant correlation between the ischemia and barnidipine-treated groups and thebarnidipine and methylprednisolone groups in terms of MDA levels (p>0.008).CONCLUSION: A single dose of barnidipine (10 mg/kg) and methylprednisolone are not effective and not sufficient to prevent spinal ischemia-reperfusion injury in rats.

🔖

Cite This Article

AK, H., DALTABAN, İ. S., TURKSOY, V. A., ÇAKIR, E., MISIR, S. (2022). The effects of barnidipine on an experimental ischemia reperfusion model of spinal cord injury and comparison with methyl prednisolone. İstanbul Kuzey Klinikleri, Cilt: 6 - Sayı: 2, 103–109. https://ajindex.com/articles/551485

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Anwar MA, Al Shehabi TS, Eid AH. Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci 2016
  2. [CrossRef ] 2. Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp (Wars) 2011
  3. 281–99. 3. Agrawal SK, Nashmi R, Fehlings MG. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience 2000
  4. 179–88. [CrossRef ] 4. Garcia E, Aguilar-Cevallos J, Silva-Garcia R, Ibarra A. Cytokine and Growth Factor Activation In Vivo and In Vitro afterSpinal Cord Injury. Mediators Inflamm 2016
  5. 9476020. [CrossRef ] 5. Fehlings MG, Tator CH, Linden RD. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989
  6. 403–16. [CrossRef ] 6. Imamura H, Tator CH. Effect of intrathecal nimodipine on spinal cord blood flow and evoked potentials in the normal or injured cord. Spinal Cord 1998
  7. 497–506. [CrossRef ] 7. Ceylan S, Ilbay K, Baykal S, Ceylan S, Sener U, Ozmenoğlu M, et al. Treatment of acute spinal cord injuries: comparison of thyrotropin-releasing hormone and nimodipine. Res Exp Med (Berl) 1992
  8. 23–33. [CrossRef ] 8. Guha A, Tator CH, Piper I. Effect of a calcium channel blocker on posttraumatic spinal cord blood flow. J Neurosurg 1987
  9. 423–30. [CrossRef ] 9. Ross IB, Tator CH. Spinal cord blood flow and evoked potential responses after treatment with nimodipine or methylprednisolone in spinal cord-injured rats. Neurosurgery 1993
  10. 470–6. [CrossRef ] 10. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigatingsecondary damage in acute spinal cord injury. Neurosurgery 1999
  11. 1027–39. [CrossRef ] 11. Bowers CA, Kundu B, Hawryluk GW. Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate. Neural Regen Res 2016
  12. 882–5. [CrossRef ] 12. Hugenholtz H, Cass DE, Dvorak MF, Fewer DH, Fox RJ, Izukawa DM, et al. High-dose methylprednisolone for acute closed spinal cord injury--only a treatment option. Can J Neurol Sci 2002
  13. 227–35. 13. Cheung V, Hoshide R, Bansal V, Kasper E, Chen CC. Methylprednisolone in the management of spinal cord injuries: Lessons from randomized, controlled trials. Surg Neurol Int 2015
  14. [CrossRef ] 14. Hall ED, Braughler JM. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982
  15. 320–7. 15. Carrillo SE, Guimarães